03/06/2024  8:00:42 Diferencia +0.580 Volumen Bid15:25:57 Ask15:25:57 Capitalización de mecado Dividendo A. P/E Ratio
11.040EUR +5.54% 0
Volumen de negocios: 0.000
11.020Volumen de oferta: 898 11.060Tamaño/ Volumen/ Formato de Ask: 497 2.43 mil millonesEUR - 26.29

Descripción de negocio

SYNLAB Group is the largest European clinical laboratory and medical diagnostic services provider by revenue and number of tests. SYNLAB offers a full range of innovative and reliable medical diagnostics for patients, practising doctors, clinics and the pharmaceutical industry. Providing the leading level of service within the industry, SYNLAB is the partner of choice for diagnostics in human and veterinary medicine. The Group continuously innovates medical diagnostic services for the benefit of patients and customers.
 

Consejo de gestión & Consejo de supervisión

CEO
Mathieu Floreani
Consejo de gestión
Sami Badarani, Robert Steinwander, Dr Santiago Valor, Luis Vieira, Henrik Andreasen, Catharina Monster, Dr Fabian Walla
Consejo de supervisión
Prof Dr David Ebsworth, Barbara Lambert, Dr Bartl Wimmer, Alex Leslie, Anastasya Molodykh-McFarlane, Christian Salling, Karin Bierstedt, Dr Stefan Graf, Dr Ute Hasholzner, Rene Schmidt-Ferroud, Marc Welters, Iris Schopper
 

Datos de la empresa

Nombre: SYNLAB AG
Dirección: Moosacher Straße 88,D-80809 München
Teléfono: +49-89-307-602-0
Fax: -
E-mail: info@synlab.com
Internet: https://www.synlab.de/
Industria: Healthcare
Sector: Healthcare Providers
Subsector: Healthcare Providers
Fin del año financiero: 31/12
Acciones de libre circulación: -
Fecha de OPI: -

Relación con inversores

Nombre: -
IR teléfono: +49 89 307602-0
IR-fax: -
IR e-mail: ir@synlab.com

Calendario de la empresa

CW 32 | 08/08/2024 Interim Report 2nd Quarter/6 Months
CW 45 | 07/11/2024 Interim Report 3rd Quarter/9 Months
 

Accionistas mayoritarios

Cinven
 
43.00%
free float
 
19.00%
Novo
 
19.00%
OTPP
 
9.00%
QIA
 
5.00%
Elliott
 
5.00%